AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2020
Oct 16, 2020
34187_dirs_2020-10-16_f846a1e2-60bf-410e-8871-c70da87835c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2020-10-12
Reporting Person: ROUBIN GARY S (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 238950 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $0.33 | 2030-10-12 | Common Stock (79650) | Direct |
Footnotes
F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service.
F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service.
More from InspireMD, Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2
Director's Dealing
2026
Feb 2